daytona52paul - I wish that was the case. From reading the remarks made during the conference call, it sounds like there is about a 2-week supply left, and that includes patients already taking it, not just new ones. I wish there was a way they could move the review of the new facility up with the FDA... sounds like the new contractor is already making the drug, they just can't sell it until it is approved by the FDA after the inspection.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.